Clinical trial
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
NCT00045591 · Alliance for Clinical Trials in Oncology, Other · Terminated
Key facts
| NCT number | NCT00045591 |
|---|---|
| Title | Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer |
| Official title | Evaluation Of Novel Therapeutic Agents (Celecoxib: NSC # 719627) Against Breast Cancer: An Innovative Randomized Phase II Trial Design |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | celecoxib, Celecoxib |
| Enrollment | 39 |
| Start date | Feb 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Jan 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: